July 20, 2015 | The Israeli drug development company Chiasma announced that it raised $102 million in a NASDAQ IPO. The company sold 6.3 million shares at $16 a piece with a market cap of $562 million. Chiasma had raised $70 million previously in a private placement. Chiasma also recently submitted its request to begin marketing its treatment for acromegaly. Chiasma was founded in 2001 and is headquartered in Jerusalem.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024

TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024

Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024

BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments